Logo image of PALI

PALISADE BIO INC (PALI) Stock Analyst Ratings

NASDAQ:PALI - Nasdaq - US6963894026 - Common Stock - Currency: USD

0.7014  +0.08 (+13.62%)

Premarket: 0.695 -0.01 (-0.91%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to PALI. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 10.88. This target is 1451.19% above the current price.
PALI was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about PALI.
In the previous month the buy percentage consensus was at a similar level.
PALI was analyzed by 9 analysts. More opinions would make the average more meaningful.
PALI Historical Analyst RatingsPALI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -56 -51 -46 -41 -36 -31 -26 -21 -16 -11 -6 -1 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 0.702.0214.2810.8816.80 - 188.00% 1,935.93% 1,451.19% 2,295.21%
PALI Current Analyst RatingPALI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2025-05-13 Brookline Capital Maintains Buy -> Buy
2024-11-20 Brookline Capital Initiate Buy
2024-11-13 Maxim Group Maintains Buy -> Buy
2024-05-01 Maxim Group Reiterate Buy -> Buy
2024-04-16 Maxim Group Maintains Buy -> Buy
2023-11-17 Maxim Group Upgrade Hold -> Buy
2023-05-16 Ladenburg Thalmann Maintains Buy -> Buy
2023-03-30 Maxim Group Upgrade Hold -> Buy
2022-08-19 Maxim Group Downgrade Buy -> Hold
2022-02-02 Ladenburg Thalmann Initiate Buy
2021-08-31 Maxim Group Initiate Buy